PatsyN,
I am for some reason assuming you are HR +/HER-Ve - maybe because we both the same chemo.
If so the CDKs studied in early disease are
Palbocliclb - Penelope study ( I think that is no,longer recruiting it was for chemo prior to surg) and Pallas ( where chemo is after surgery)
Abemaciclib ( a tighter tumour criteria - a higher tumour load ) Monarch E study still recruiting as far as I know.
You can find them using the "clinical trials.gov" site ( it will tell you recruiting, where, inclusion criteria) - just use their search engine - put in Breast Cancer and the drug name and a list comes up. Some are in Metastatic disease and some are used drugs in early disease.
It may not be relevant to you - and I won't say more because no one knows the results of this work yet - but worth five minute chat to your oncologist I would think. Maybe....
